Viagra-Type drug may shield heart pump users from strokes and bleeding
NCT ID NCT06510322
Summary
This study is testing whether sildenafil (the active ingredient in Viagra) can protect blood vessels in people with advanced heart failure who use a mechanical heart pump (LVAD). The goal is to see if the drug can reduce the rapid aging and damage that happens to blood vessels while using the pump, which often leads to serious complications like stroke and bleeding. Researchers will compare changes in blood vessel health between 50 participants taking sildenafil or a placebo over six months.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VASCULAR DISEASES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Montefiore Medical Center
RECRUITINGThe Bronx, New York, 10461, United States
Conditions
Explore the condition pages connected to this study.